version 17 3 Search Results


90
Minitab Inc fisher’s test minitab version 17.3.1
Fisher’s Test Minitab Version 17.3.1, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fisher’s test minitab version 17.3.1/product/Minitab Inc
Average 90 stars, based on 1 article reviews
fisher’s test minitab version 17.3.1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
AUTODOCK GmbH chimera-autodock version 1.17.3
Phosphokinases and Tau phosphosites.
Chimera Autodock Version 1.17.3, supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chimera-autodock version 1.17.3/product/AUTODOCK GmbH
Average 90 stars, based on 1 article reviews
chimera-autodock version 1.17.3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Minitab Inc for windows version 17.3.0
Phosphokinases and Tau phosphosites.
For Windows Version 17.3.0, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/for windows version 17.3.0/product/Minitab Inc
Average 90 stars, based on 1 article reviews
for windows version 17.3.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Allscripts professional emr version 17.3.1
Phosphokinases and Tau phosphosites.
Professional Emr Version 17.3.1, supplied by Allscripts, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/professional emr version 17.3.1/product/Allscripts
Average 90 stars, based on 1 article reviews
professional emr version 17.3.1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Molecular Dynamics Inc chimera version 1.17.3
Phosphokinases and Tau phosphosites.
Chimera Version 1.17.3, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chimera version 1.17.3/product/Molecular Dynamics Inc
Average 90 stars, based on 1 article reviews
chimera version 1.17.3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
RStudio rstudio version 8.10.173.987
Phosphokinases and Tau phosphosites.
Rstudio Version 8.10.173.987, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rstudio version 8.10.173.987/product/RStudio
Average 90 stars, based on 1 article reviews
rstudio version 8.10.173.987 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
RStudio seurat r package version 4.173
Phosphokinases and Tau phosphosites.
Seurat R Package Version 4.173, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/seurat r package version 4.173/product/RStudio
Average 90 stars, based on 1 article reviews
seurat r package version 4.173 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
ChemAxon LLC marvin sketch version 17.3
Phosphokinases and Tau phosphosites.
Marvin Sketch Version 17.3, supplied by ChemAxon LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/marvin sketch version 17.3/product/ChemAxon LLC
Average 90 stars, based on 1 article reviews
marvin sketch version 17.3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Minitab Inc (version 17.3, 2013)
Phosphokinases and Tau phosphosites.
(Version 17.3, 2013), supplied by Minitab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/(version 17.3, 2013)/product/Minitab Inc
Average 90 stars, based on 1 article reviews
(version 17.3, 2013) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Phosphokinases and Tau phosphosites.

Journal: Molecules

Article Title: Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [ 125 I]Radioiodinated DYRK1A Inhibitor

doi: 10.3390/molecules30050990

Figure Lengend Snippet: Phosphokinases and Tau phosphosites.

Article Snippet: Using Chimera-Autodock (version 1.17.3; 2023) as previously described for our experiments with Tau ligands [ ], DYRK1A (PDB 4YLL [ ]) was used to model the various molecules for DYRK1A binding energy calculations.

Techniques: Clinical Proteomics

Schematic showing chromosome 21 with the Down’s syndrome critical region (DSCR) highlighted. Expression of DYRK1A is regulated by DSCR and is upregulated in Down’s syndrome (#1 blue dotted line). Membrane-bound DYRK1A may play a role in the hyperphosphorylation of Tau (#2 blue dotted line), resulting in the formation of neurofibrillary tangles (#3 blue dotted line). (Orange star: DYRK1A kinase; Green circles: normal Tau; Orange circles: phosphorylated Tau; Orange lines: Tau tangles).

Journal: Molecules

Article Title: Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [ 125 I]Radioiodinated DYRK1A Inhibitor

doi: 10.3390/molecules30050990

Figure Lengend Snippet: Schematic showing chromosome 21 with the Down’s syndrome critical region (DSCR) highlighted. Expression of DYRK1A is regulated by DSCR and is upregulated in Down’s syndrome (#1 blue dotted line). Membrane-bound DYRK1A may play a role in the hyperphosphorylation of Tau (#2 blue dotted line), resulting in the formation of neurofibrillary tangles (#3 blue dotted line). (Orange star: DYRK1A kinase; Green circles: normal Tau; Orange circles: phosphorylated Tau; Orange lines: Tau tangles).

Article Snippet: Using Chimera-Autodock (version 1.17.3; 2023) as previously described for our experiments with Tau ligands [ ], DYRK1A (PDB 4YLL [ ]) was used to model the various molecules for DYRK1A binding energy calculations.

Techniques: Expressing, Membrane

Chemical structures of compounds with reported binding profiles. 1 . Harmine, binds to DYRK1A and MAO-A; 2 . 10-bromo-2-iodo-11 H -indolo[3,2-c]quinoline-6-carboxylic acid (4E3) binds to DYRK1A; 3 . 10-iodo-11 H -indolo[3,2-c]quinoline-6-carboxylic acid (KuFal184) binds to DYRK1A.

Journal: Molecules

Article Title: Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [ 125 I]Radioiodinated DYRK1A Inhibitor

doi: 10.3390/molecules30050990

Figure Lengend Snippet: Chemical structures of compounds with reported binding profiles. 1 . Harmine, binds to DYRK1A and MAO-A; 2 . 10-bromo-2-iodo-11 H -indolo[3,2-c]quinoline-6-carboxylic acid (4E3) binds to DYRK1A; 3 . 10-iodo-11 H -indolo[3,2-c]quinoline-6-carboxylic acid (KuFal184) binds to DYRK1A.

Article Snippet: Using Chimera-Autodock (version 1.17.3; 2023) as previously described for our experiments with Tau ligands [ ], DYRK1A (PDB 4YLL [ ]) was used to model the various molecules for DYRK1A binding energy calculations.

Techniques: Binding Assay

 DYRK1A  and Tau binding energies of agents.

Journal: Molecules

Article Title: Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [ 125 I]Radioiodinated DYRK1A Inhibitor

doi: 10.3390/molecules30050990

Figure Lengend Snippet: DYRK1A and Tau binding energies of agents.

Article Snippet: Using Chimera-Autodock (version 1.17.3; 2023) as previously described for our experiments with Tau ligands [ ], DYRK1A (PDB 4YLL [ ]) was used to model the various molecules for DYRK1A binding energy calculations.

Techniques: Binding Assay

( A ). DYRK1A (PDB 4YLL protein structure used for binding energy measurements of various molecules; ( B ). Interaction of KuFAL184 at the binding site of DYRK1A. Three residues of DYRK1A binding site have been highlighted in red, including Leu241, Asp307, and Lys188. The high affinity of KuFal184 is driven by the “salt bridge” interaction between the carboxylate group in KuFal184 and Lys188.

Journal: Molecules

Article Title: Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [ 125 I]Radioiodinated DYRK1A Inhibitor

doi: 10.3390/molecules30050990

Figure Lengend Snippet: ( A ). DYRK1A (PDB 4YLL protein structure used for binding energy measurements of various molecules; ( B ). Interaction of KuFAL184 at the binding site of DYRK1A. Three residues of DYRK1A binding site have been highlighted in red, including Leu241, Asp307, and Lys188. The high affinity of KuFal184 is driven by the “salt bridge” interaction between the carboxylate group in KuFal184 and Lys188.

Article Snippet: Using Chimera-Autodock (version 1.17.3; 2023) as previously described for our experiments with Tau ligands [ ], DYRK1A (PDB 4YLL [ ]) was used to model the various molecules for DYRK1A binding energy calculations.

Techniques: Binding Assay

DYRK1A (PDB 4YLL ) Chimera-Autodock molecular models: energy-minimized comparative chemical structures in the binding site. ( A ). Energy-minimized comparison of KuFal184 and IPPI at the DYRK1A binding site; ( B ). Energy-minimized comparison of KuFal184 and MK-6240 at the DYRK1A binding site; ( C ). Energy-minimized comparison of harmine and IPPI at the DYRK1A binding site; ( D ). Energy-minimized comparison of harmine and MK-6240 at the DYRK1A binding site.

Journal: Molecules

Article Title: Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [ 125 I]Radioiodinated DYRK1A Inhibitor

doi: 10.3390/molecules30050990

Figure Lengend Snippet: DYRK1A (PDB 4YLL ) Chimera-Autodock molecular models: energy-minimized comparative chemical structures in the binding site. ( A ). Energy-minimized comparison of KuFal184 and IPPI at the DYRK1A binding site; ( B ). Energy-minimized comparison of KuFal184 and MK-6240 at the DYRK1A binding site; ( C ). Energy-minimized comparison of harmine and IPPI at the DYRK1A binding site; ( D ). Energy-minimized comparison of harmine and MK-6240 at the DYRK1A binding site.

Article Snippet: Using Chimera-Autodock (version 1.17.3; 2023) as previously described for our experiments with Tau ligands [ ], DYRK1A (PDB 4YLL [ ]) was used to model the various molecules for DYRK1A binding energy calculations.

Techniques: Binding Assay, Comparison